Mar 12, 2018 11:00 am UTC| Business
TEN Celebrates 25 years as a Public Company – To Ring the Opening Bell at the NYSE on March 14, 2018 30% Fleet Expansion Successfully Completed 15 New Vessels All with Long Term Contracts to Solid Counterparties RECENT...
BlueLinx Enters Into Strategic Merger Agreement to Acquire Cedar Creek
Mar 12, 2018 11:00 am UTC| Business
– Creates Diversified Two-Step Distributor with $3.2 Billion in Revenue – – Enhances Position as a Leading Building Products Wholesale Distributor with Expanded Offerings, Capabilities and Geographic Reach to Accelerate...
Rosehill Resources Provides Operational Update
Mar 12, 2018 11:00 am UTC| Business
HOUSTON, March 12, 2018 -- Rosehill Resources Inc. (“Rosehill” or the “Company”) (NASDAQ:ROSE) (NASDAQ:ROSEW) (NASDAQ:ROSEU) provided an operational update focused on production levels and the preliminary 2018...
Lightbridge Receives Japanese Patent Approval for Innovative Metallic Fuel Design
Mar 12, 2018 11:00 am UTC| Business
RESTON, Va., March 12, 2018 -- Lightbridge Corporation (NASDAQ:LTBR), a nuclear fuel technology company, has received notice of allowance for a divisional patent in Japan related to the manufacturing of its metallic...
Neuralstem to Participate at Upcoming Investor Conferences
Mar 12, 2018 11:00 am UTC| Business
GERMANTOWN, Md., March 12, 2018 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that members of the management team will participate...
Humanigen Appoints Robert Savage to Board of Directors
Mar 12, 2018 11:00 am UTC| Business
BRISBANE, Calif., March 12, 2018 -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments,...
Mar 12, 2018 11:00 am UTC| Business
Initiates Financial Guidance for Full Year 2018Management to Host Conference Call at 8:00 AM ET today WAYNE, Pa., March 12, 2018 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical...